Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Established Investigators
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
2022 Rheumatology Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Innovative Digital Health Projects in Oncology
Release Date:
Review Process: Expert Review Panel
Quality Improvement Oncology Italy
BRAF V600-mutant colorectal cancer: disease education and therapy management
Release Date:
Partner: Lilly
Review Process: Pfizer Internal
Education Oncology USA
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Rare Disease Canada
Heart Failure and Cardiomyopathy Leading to Differential Diagnoses of Cardiac Amyloidosis
Release Date:
Review Process: Pfizer Internal
Education Rare Disease Japan
Establish a System to Refer Patients with Suspected Cardiomyopathy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Rare Disease Japan
Improving the care of patients living with metastatic breast cancer (mBC)
Release Date:
Partner: Rethink Breast Cancer
Review Process: Expert Review Panel
Quality Improvement Oncology Canada
Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities
Release Date:
Partner: BSAC
Review Process: Expert Review Panel
Quality Improvement Hospital All
Global ATTR Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Promotion of Smoking Cessation Treatment in General Practice
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan